Northern Trust Corp Centessa Pharmaceuticals PLC Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.45 - $11.59 $66,185 - $102,965	-8,884 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$10.99 - $17.54 $97,635 - $155,825	8,884 New	8,884 $100,000
Q3 2021 Nov 15, 2021	SELL	$16.7 - $23.11 $307,280 - $425,224	-18,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$21.71 - $25.66 $399,464 - $472,144	18,400 New	18,400 $409,000

108

118M

5.9K

53K

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.65B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.